The safety of two Bacillus probiotic strains for human use

Digestive Diseases and Sciences

Volumn 53, Issue 4, 2008, Pages 954-963

  Sorokulova, Iryna B ^a   Pinchuk, Iryna V ^a   Denayrolles, Muriel ^a   Osipova, Irina G ^b   Huang, Jen M ^c   Cutting, Simon M ^c   Urdaci, Maria C ^a  

^a CNRS   (France)

^b Tarasevic State Institute for the Standardization and Control of Medical Biological Preparations   (France)

^c UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Antimicrobials resistance; Bacillus; Probiotics; Safety; Toxicity

Indexed keywords

AMOXICILLIN; AMPICILLIN; BACTISUBTIL; BIOSUBTYL; CARBENICILLIN; CEFALOTIN; CEFAMANDOLE; CEFAZOLIN; CEFOTAXIME; CEFOXITIN; CEREOBIOGEN; CHLORAMPHENICOL; CIPROFLOXACIN; CLINDAMYCIN; DALFOPRISTIN PLUS QUINUPRISTIN; ENROFLOXACIN; ENTEROGERMINA; ERYTHROMYCIN; GENTAMICIN; IMIPENEM; KANAMYCIN; LINEZOLID; METICILLIN; MEZLOCILLIN; NEOMYCIN; OXACILLIN; PROBIOTIC AGENT; RIFAMPICIN; STREPTOMYCIN; TETRACYCLINE; TICARCILLIN; TRIMETHOPRIM; UNCLASSIFIED DRUG; UNINDEXED DRUG; VANCOMYCIN;

ANIMAL EXPERIMENT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACILLUS CEREUS; BACILLUS LICHENIFORMIS; BACILLUS SUBTILIS; CHRONIC TOXICITY; CONTROLLED STUDY; DRUG EFFECT; DRUG SAFETY; HISTOPATHOLOGY; HUMAN; HUMAN CELL; MALE; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL;

ANIMALS; ANIMALS, NEWBORN; BACILLUS; BIOLOGICAL FACTORS; DRUG RESISTANCE, BACTERIAL; ENTEROTOXINS; MALE; MICE; MICE, INBRED BALB C; PROBIOTICS; RABBITS; SWINE; TOXICITY TESTS; VIRULENCE;

EID: 40749162407     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10620-007-9959-1     Document Type: Article

References (47)

1. Hammerman C, Bin-Nun A, Kaplan M (2006) Safety of probiotics: comparison of two popular strains. BMJ 333:1006-1008
2. Saarela M, Mogensen G, Fonden R, Matto J, Mattila-Sandholm T (2000) Probiotic bacteria: safety, functional and technological properties. J Biotechnol 84:197-215
3. Hong HA, Duc LH, Cutting SM (2005) The use of bacterial spore formers as probiotics. FEMS Microbiol Rev 29:813-835
4. Mazza P (1994) The use of Bacillus subtilis as an antidiarrhoeal microorganism. Boll Chim Farm 133:3-118
5. Rolfe RD (2000) The role of probiotic cultures in the control of gastrointestinal health. J Nutr 130:396S-402S
6. Rowland I (1999) Probiotics and benefits to human health-the evidence in favour. Environ Microbiol 1:375-376
7. Urdaci MC, Pinchuk I (2004) Antimicrobial activity of Bacillus probiotics In: Ricca E, Henriques AO, Cutting SM (eds) Bacterial spore formers: probiotics and emerging applications. Horizon Bioscience, Norfolk, UK, pp 171-182
8. Logan NA (2004) Safety of aerobic endospore-forming bacteria. In: Ricca E, Henriques AO, Cutting SM (eds) Bacterial spore formers: probiotics and emerging applications. Horizon Bioscience, Norfolk, UK, pp 93-106
9. Workowski KA, Flaherty JP (1992) Systemic Bacillus species infection mimicking listeriosis of pregnancy. Clin Infect Dis 14:694-966
10. Wu YJ, Hong TC, Hou CJ, Chou YS, Tsai CH, Yang DI (1999) Bacillus popilliae endocarditis with prolonged complete heart block. Am J Med Sci 317:263-265
11. Drobniewski FA (1993) Bacillus cereus and related species. Clin Microbiol Rev 6:324-338
12. Salkinoja-Salonen MS, Vuorio R, Andersson MA, Kampfer P, Andersson MC, Honkanen-Buzalski T, Scoging AC (1999) Toxigenic strains of Bacillus licheniformis related to food poisoning. Appl Environ Microbiol 65:4637-4645
13. Duc LH, Hong HA, Barbosa TM, Henriques AO, Cutting SM (2004) Characterization of Bacillus probiotics available for human use. Appl Environ Microbiol 70:2161-2171
14. From C, Pukall R, Schumann P, Hormazabal V, Granum PE (2005) Toxin-producing ability among Bacillus spp. outside the Bacillus cereus group. Appl Environ Microbiol 71:1178-1183
15. Phelps RJ, McKillip JL (2002) Enterotoxin production in natural isolates of Bacillaceae outside the Bacillus cereus group. Appl Environ Microbiol 68:3147-3151
16. Rowan NJ, Caldow G, Gemmell CG, Hunter IS (2003) Production of diarrheal enterotoxins and other potential virulence factors by veterinary isolates of bacillus species associated with nongastrointestinal infections. Appl Environ Microbiol 69:2372-2376
17. FAO/WHO (2002) Joint FAO/WHO (Food and Agriculture Organization/World Health Organization) working group report on drafting guidelines for the evaluation of probiotics in food. London, Ontario, Canada
18. Sanders ME (2003) Probiotics: considerations for human health. Nutr Rev 61:91-99
19. European Food Safety Authority (2005) Opinion of the Scientific Committee on a request from EFSA related to a generic approach to the safety assessment by EFSA of microorganisms used in food/feed and the production of food/feed additives. EFSA J 226:1-12
20. Gracheva NM, Gavrilov AF, Solov'eva AI, Smirnov VV, Sorokulova IB, Reznik SR, Chudnovskaia NV (1996) The efficacy of the new bacterial preparation biosporin in treating acute intestinal infections. Zh Mikrobiol Epidemiol Immunobiol 1:75-77
21. Smirnov VV, Reznik SR, V'iunitskaia VA, Sorokulova IB, Samgorodskaia NV, Tofan AV (1993) The current concepts of the mechanisms of the therapeutic-prophylactic action of probiotics from bacteria in the genus Bacillus. Mikrobiol Z 55:92-112
22. Sorokulova IB (1996) Outlook for using bacteria of the genus Bacillus for the design of new biopreparations. Antibiot Khimioter 41:13-15
23. Sorokulova IB (1998) The safety and reactogenicity of the new probiotic subalin for volunteers. Mikrobiol Z 60:43-46
24. Youngman P, Perkins J, Losick R (1984) Construction of a cloning site near one end of Tn917 into which foreign DNA may be inserted without affecting transposition in Bacillus subtilis or expression of the transposon-borne erm gene. Plasmid 12:1-9
25. Hoa NT, Baccigalupi L, Huxham A, Smertenko A, Van PH, Ammendola S, Ricca E, Cutting SM (2000) Characterization of Bacillus species used for oral bacteriotherapy and bacterioprophylaxis of gastrointestinal disorders. Appl Environ Microbiol 66:5241-5247
26. Sneath PHA (1986) Endospore-forming gram-positive rods and cocci. In: Mair NS, Sharpe ME, Holt JG (eds) Bergey's manual of systematic bacteriology 2. Lippincott Williams &Wilkins, Baltimore, pp 1104-1207
27. Reva ON, Sorokulova IB, Smirnov VV (2001) Simplified technique for identification of the aerobic spore-forming bacteria by phenotype. Int J Syst Evol Microbiol 51:1361-1371
28. Hyronimus B, Le Marrec C, Urdaci MC (1998) Coagulin, a bacteriocin-like inhibitory substance produced by Bacillus coagulans I4. J Appl Microbiol. 85:42-50
29. Weisburg WG, Barns SM, Pelletier DA, Lane DJ (1991) 16S ribosomal DNA amplification for phylogenetic study. J Bacteriol 173:697-703
30. Pinchuk IV, Bressollier P, Sorokulova IB, Verneuil B, Urdaci MC (2002) Amicoumacin antibiotic production and genetic diversity of Bacillus subtilis strains isolated from different habitats. Res Microbiol 153:269-276
31. Voskuil MI, Chambliss GH (1993) Rapid isolation and sequencing of purified plasmid DNA from Bacillus subtilis. Appl Environ Microbiol 59:1138-1142
32. National Committee for Clinical Laboratory Standards (NCCLS) (1997) Performance standards for antimicrobial disk susceptibility tests, 6th edn. Approved standard M2-A5. National Committee for Clinical Laboratory standards, Wayne, PA
33. Guinebretiere MH, Broussolle V, Nguyen-The C (2002) Enterotoxigenic profiles of food-poisoning and food-borne Bacillus cereus strains. J Clin Microbiol 40:3053-3056
34. Tallon R, Arias S, Bressollier P, Urdaci MC (2007) Strain- and matrix-dependent adhesion of Lactobacillus plantarum is mediated by proteinaceous bacterial compounds. J Appl Microbiol 102:442-451
35. Pinchuk I, Starcher BC, Livingston B, Tvninnereim A, Wu S, Appella E, Sidney J, Sette A, Wizel B (2005) A CD8+ T cell heptaepitope minigene vaccine induces protective immunity against Chlamydia pneumoniae. J Immunol 174:5729-5739
36. Duc LH, Dong TC, Logan NA, Sutherland AD, Taylor J, Cutting SM (2005) Cases of emesis associated with bacterial contamination of an infant breakfast cereal product. Int J Food Microbiol 102:245-251
37. Scientific Committee on Animal Nutrition (2000) SCAN opinion on the safety of use of Bacillus species in animal nutrition http://www.europa.eu.int/ comm/food/fs/sc/scan/out41_en.pdf
38. Green DH, Wakeley PR, Page A, Barnes A, Baccigalupi L, Ricca E, Cutting SM (1999) Characterization of two Bacillus probiotics. Appl Environ Microbiol 65:4288-4291
39. Senesi S, Celandroni F, Tavanti A, Ghelardi E (2001) Molecular characterization and identification of Bacillus clausii strains marketed for use in oral bacteriotherapy. Appl.Environ.Microbiol 67:834-839
40. Silley P (2006) Do bacteria need to be regulated? J Appl Microbiol 101:607-615
41. von Wright A (2005) Regulating the safety of probiotics-the European approach. Curr Pharm Des 11:17-23
42. Ivanova EP, Vysotskii MV, Svetashev VI, Nedashkovskaya OI, Gorshkova NM, Mikhailov VV, Yumoto N, Shigeri Y, Taguchi T, Yoshikawa S (1999) Characterization of Bacillus strains of marine origin. Int Microbiol 2:267-271
43. Reva ON, Vyunitskaya VA, Reznik SR, Kozachko IA, Smirnov VV (1995) Antibiotic susceptibility as a taxonomic characteristic of the genus Bacillus. Int J Syst Bacteriol 45:409-411
44. Pinchuk IV, Bressollier P, Verneuil B, Fenet B, Sorokulova IB, Megraud F, Urdaci MC (2001) In vitro anti-Helicobacter pylori activity of the probiotic strain Bacillus subtilis 3 is due to secretion of antibiotics. Antimicrob Agents Chemother 45:3156-3161
45. Donohue DC (2006) Safety of probiotics. Asia Pac J Clin Nutr 15:563-569
46. Zhou JS, Shu Q, Rutherfurd KJ, Prasad J, Birtles MJ, Gopal PK, Gill HS (2000) Safety assessment of potential probiotic lactic acid bacterial strains Lactobacillus rhamnosus HN001, Lb. acidophilus HN017, and Bifidobacterium lactis HN019 in BALB/c mice. Int J Food Microbiol 56:87-96
47. Osipova IG, Sorokulova IB, Tereshkina NV, Grigor'eva LV (1998) Safety of bacteria of the genus Bacillus, forming the base of some probiotics. Zh Mikrobiol Epidemiol Immunobiol 6:68-70